Foster Wheeler secures repeat business with MSD Singapore
Foster Wheeler Eastern, a subsidiary of Foster Wheeler International, has been awarded an engineering, procurement and construction contract by Merck, Sharp & Dohme (MSD) for work to be executed within MSD's existing multi-purpose primary production facility located within the pharmaceutical zone at Tuas, Singapore.
'This award reflects our continued successful working relationship with MSD and our outstanding pharmaceutical track record in Singapore,' said Clive Mullins, global business development director, pharmaceuticals, Foster Wheeler International. 'It follows our successful handover last year of MSD's new secondary facility in Singapore, on schedule, under budget, and with an award-winning safety performance.'
Under the scope of the contract, Foster Wheeler will partially fit out spare bays within the existing building that it previously designed, constructed and completed for MSD in 2002.
Because the work will be carried out while the plant is still operating, measures have been taken to isolate the work areas, and a strict permit-to-work system will be necessary. System tie-in works will be executed during pre-planned shutdown operations when manufacturing activities will have ceased or are running at reduced levels.
